TOKYO, Oct. 6 -- Japan Patent Office issued the following news: Mr. João Negrão, Executive Director of the European Union Intellectual Property Office (EUIPO)*, visited the Japan Patent Off... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059300) titled 'Changes in Mood and Autonomic Nervous System Activity During Aromatherapy So... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059305) titled 'Effects of Near-Infrared Light Irradiation on the Stellate Ganglion on the B... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059304) titled 'Analysis of Local Field Potentials Using SEEG and DBS in Refractory Epilepsy... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059303) titled 'Effects of test food consumption on subjective fatigue in healthy Japanese: ... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059299) titled 'Relationship Between Visual Reaction Time During Sudden Braking in a Driving... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059298) titled 'Development of a simulated driving test with eye measurement for stroke and ... Read More
Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059296) titled 'The Effects of Delayed Feedback on Task Performance and Cerebral Hemodynamic... Read More
Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059262) titled 'Efficacy of 12-week continuous application lipids derived from animal at two... Read More
Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059294) titled 'A biomarker study associated with a randomized, prospective phase II trial c... Read More